1. Home
  2. PODD vs SHG Comparison

PODD vs SHG Comparison

Compare PODD & SHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • SHG
  • Stock Information
  • Founded
  • PODD 2000
  • SHG 1982
  • Country
  • PODD United States
  • SHG South Korea
  • Employees
  • PODD N/A
  • SHG N/A
  • Industry
  • PODD Medical/Dental Instruments
  • SHG Major Banks
  • Sector
  • PODD Health Care
  • SHG Finance
  • Exchange
  • PODD Nasdaq
  • SHG Nasdaq
  • Market Cap
  • PODD 16.5B
  • SHG 17.6B
  • IPO Year
  • PODD 2007
  • SHG N/A
  • Fundamental
  • Price
  • PODD $282.80
  • SHG $33.54
  • Analyst Decision
  • PODD Buy
  • SHG
  • Analyst Count
  • PODD 16
  • SHG 0
  • Target Price
  • PODD $291.81
  • SHG N/A
  • AVG Volume (30 Days)
  • PODD 598.2K
  • SHG 281.6K
  • Earning Date
  • PODD 02-20-2025
  • SHG 02-06-2025
  • Dividend Yield
  • PODD N/A
  • SHG 3.60%
  • EPS Growth
  • PODD 96.40
  • SHG 13.52
  • EPS
  • PODD 5.78
  • SHG 6.61
  • Revenue
  • PODD $2,071,600,000.00
  • SHG $11,370,066,828.00
  • Revenue This Year
  • PODD $23.56
  • SHG N/A
  • Revenue Next Year
  • PODD $18.07
  • SHG $1.13
  • P/E Ratio
  • PODD $48.93
  • SHG $4.90
  • Revenue Growth
  • PODD 22.07
  • SHG 7.39
  • 52 Week Low
  • PODD $160.19
  • SHG $29.25
  • 52 Week High
  • PODD $289.46
  • SHG $46.05
  • Technical
  • Relative Strength Index (RSI)
  • PODD 54.94
  • SHG 40.82
  • Support Level
  • PODD $270.00
  • SHG $33.41
  • Resistance Level
  • PODD $288.95
  • SHG $34.29
  • Average True Range (ATR)
  • PODD 6.83
  • SHG 0.56
  • MACD
  • PODD -0.31
  • SHG -0.07
  • Stochastic Oscillator
  • PODD 65.78
  • SHG 9.31

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About SHG Shinhan Financial Group Co Ltd

Shinhan Financial is a Korean banking group. Along with its subsidiaries the company provides, comprehensive financial services which consist of commercial banking services, credit card services, securities services, insurance, credit services, and asset management services, including securities investment trust management, investment advisory, call transaction, domestic and foreign private equity fund business, and other services. The majority of the revenue is generated from its Banking business which includes retail, corporate, international, and other banking services the company offers.

Share on Social Networks: